Skip to main content
Top
Published in: Lung 5/2006

01-10-2006 | INTERSTITIAL LUNG DISEASE

Green Tea Extract Inhibits Paraquat-Induced Pulmonary Fibrosis by Suppression of Oxidative Stress and Endothelin-l Expression

Authors: Hak-Ryul Kim, Byung-Kyu Park, Yeon-Mok Oh, Yun-Song Lee, Dong-Soon Lee, Hyun-Kuk Kim, Joo-Young Kim, Tae-Sun Shim, Sang-Do Lee

Published in: Lung | Issue 5/2006

Login to get access

Abstract

Paraquat-induced pulmonary fibrosis involves two factors, direct injury by oxygen free radicals and indirect injury by inflammatory cells and fibroblasts. Endothelin-1 (ET-1) has been shown to act as a mediator of pulmonary fibrosis, and its formation increases during oxidative stress. We investigated whether green tea extract (GTE), which has antioxidant properties, inhibits paraquat-induced pulmonary fibrosis and whether ET-1 is involved in this process. Paraquat (0.3 mg/kg) was instilled into the right lungs of rats, following which the rats were either not further treated (Group P, n = 7), or they were administered 1% GTE mixed with feed (Group PG; n = 7) or the ETA receptor antagonist ZD2574 (10 mg/kg through gavage; Group PZ; n = 7) for two weeks. As control, we used rats instilled with saline (Group N; n = 6). Two weeks after paraquat instillation, we assayed the degree of pulmonary fibrosis by light microscopic morphometry and hydroxyproline content; lipid peroxidation as a marker of oxidative stresses by measurement of malondialdehyde (MDA); ET-1 by immunohistochemistry; and prepro-ET-1 mRNA expression by reverse transcription-polymerase chain reaction. Compared with Group N, significant pulmonary fibrosis was observed in Group P, accompanied by increases in MDA, ET-1, and prepro-ET-1 mRNA expression. Compared with Group P, Group PG showed significant decreases in pulmonary fibrosis, along with decreases in MDA, ET-1, and prepro-ET-1 mRNA expression. We also observed significant decreases in pulmonary fibrosis in Group PZ compared with Group P. These findings suggest that GTE inhibits paraquat-induced pulmonary fibrosis by suppression of oxidative stress and ET-1 expression.
Literature
1.
go back to reference Anjaneyulu M, Tirkey N, Chopra K (2003) Attenuation of cyclosporine-induced renal dysfunction by catechin: possible antioxidant mechanism. Ren Fail 25:691–707PubMedCrossRef Anjaneyulu M, Tirkey N, Chopra K (2003) Attenuation of cyclosporine-induced renal dysfunction by catechin: possible antioxidant mechanism. Ren Fail 25:691–707PubMedCrossRef
2.
3.
go back to reference Barnes PJ (1994) Endothelins and pulmonary diseases. J Appl Phsiol 77:1051–1059 Barnes PJ (1994) Endothelins and pulmonary diseases. J Appl Phsiol 77:1051–1059
4.
go back to reference Coker RK, Laurent GJ (1998) Pulmonary fibrosis: cytokines in the balance. Eur Respir J 11:1218–1221PubMedCrossRef Coker RK, Laurent GJ (1998) Pulmonary fibrosis: cytokines in the balance. Eur Respir J 11:1218–1221PubMedCrossRef
5.
go back to reference Conte A, Pellegrini S, Tagliazucchi D (2003) Synergistic protection of PC 12 cells from beta-amyloid toxicity by resveratrol and catechin. Brain Res Bull 62:29–38PubMedCrossRef Conte A, Pellegrini S, Tagliazucchi D (2003) Synergistic protection of PC 12 cells from beta-amyloid toxicity by resveratrol and catechin. Brain Res Bull 62:29–38PubMedCrossRef
6.
go back to reference Cooper JA Jr, Zitnik RJ, Matthay RA (1988) Mechanisms of drug-induced pulmonary disease. Annu Rev Med 39:395–404PubMedCrossRef Cooper JA Jr, Zitnik RJ, Matthay RA (1988) Mechanisms of drug-induced pulmonary disease. Annu Rev Med 39:395–404PubMedCrossRef
7.
go back to reference Copland GM, Kolin A, Shulman HS (1974) Fatal pulmonary intra-alveolar fibrosis after paraquat ingestion. N Engl J Med 291:290–292PubMedCrossRef Copland GM, Kolin A, Shulman HS (1974) Fatal pulmonary intra-alveolar fibrosis after paraquat ingestion. N Engl J Med 291:290–292PubMedCrossRef
8.
go back to reference Dubaybo BA, Durr RA, Thet LA (1987) Unilateral paraquat-induced lung fibrosis: evolution of changes in lung fibronectin and collagen after graded degrees of lung injury. J Toxicol Environ Health 22:439–457PubMedCrossRef Dubaybo BA, Durr RA, Thet LA (1987) Unilateral paraquat-induced lung fibrosis: evolution of changes in lung fibronectin and collagen after graded degrees of lung injury. J Toxicol Environ Health 22:439–457PubMedCrossRef
9.
go back to reference Frei B, Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275S–3284SPubMed Frei B, Higdon JV (2003) Antioxidant activity of tea polyphenols in vivo: evidence from animal studies. J Nutr 133:3275S–3284SPubMed
10.
go back to reference Fujiki H, Suganuma M, Okabe S, et al. (2000) A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (−)-epigallocatechin gallate and green tea–a review. Cancer Detect Prev 24:91–99PubMed Fujiki H, Suganuma M, Okabe S, et al. (2000) A new concept of tumor promotion by tumor necrosis factor-alpha, and cancer preventive agents (−)-epigallocatechin gallate and green tea–a review. Cancer Detect Prev 24:91–99PubMed
11.
go back to reference Gauldie J, Jordana M, Cox G (1993) Cytokines and pulmonary fibrosis. Thorax 48:931–935PubMed Gauldie J, Jordana M, Cox G (1993) Cytokines and pulmonary fibrosis. Thorax 48:931–935PubMed
12.
go back to reference Giaid A, Michel RP, Stewart DJ, et al. (1993) Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 341:1550–1554PubMedCrossRef Giaid A, Michel RP, Stewart DJ, et al. (1993) Expression of endothelin-1 in lungs of patients with cryptogenic fibrosing alveolitis. Lancet 341:1550–1554PubMedCrossRef
13.
go back to reference Greenberg DB, Lyons SA, Last JA (1978) Paraquat-induced changes in the rate of collagen synthesis by rat lung explants. J Lab Clin Med 92:1033–1042PubMed Greenberg DB, Lyons SA, Last JA (1978) Paraquat-induced changes in the rate of collagen synthesis by rat lung explants. J Lab Clin Med 92:1033–1042PubMed
14.
go back to reference Greenberg DB, Reiser KM, Last JA (1978) Correlation of biochemical and morphologic manifestations of acute pulmonary fibrosis in rats administered paraquat. Chest 74:421–425PubMed Greenberg DB, Reiser KM, Last JA (1978) Correlation of biochemical and morphologic manifestations of acute pulmonary fibrosis in rats administered paraquat. Chest 74:421–425PubMed
15.
go back to reference Henry JP, Stephens-Larson P (1984) Reduction of chronic psychosocial hypertension in mice by decaffeinated tea. Hypertension 6:437–444PubMed Henry JP, Stephens-Larson P (1984) Reduction of chronic psychosocial hypertension in mice by decaffeinated tea. Hypertension 6:437–444PubMed
16.
go back to reference Higuchi A, Yonemitsu K, Koreeda A, Tsunenari S (2003) Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidationr—a mechanism of protective effects of EGCg against paraquat toxicity. Toxicology 183:143–149PubMedCrossRef Higuchi A, Yonemitsu K, Koreeda A, Tsunenari S (2003) Inhibitory activity of epigallocatechin gallate (EGCg) in paraquat-induced microsomal lipid peroxidationr—a mechanism of protective effects of EGCg against paraquat toxicity. Toxicology 183:143–149PubMedCrossRef
17.
go back to reference Hocher B, Schwarz A, Fagan KA, et al. (2000) Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Mol Biol 23:19–26PubMed Hocher B, Schwarz A, Fagan KA, et al. (2000) Pulmonary fibrosis and chronic lung inflammation in ET-1 transgenic mice. Am J Respir Cell Mol Biol 23:19–26PubMed
18.
go back to reference Hsu SM, Raine L, Fanger H (1981) Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580PubMed Hsu SM, Raine L, Fanger H (1981) Use of avidin–biotin–peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29:577–580PubMed
19.
go back to reference Isemura M, Saeki K, Kimura T, et al. (2000) Tea catechins and related polyphenols as anti-cancer agents. Biofactors 13:81–85PubMed Isemura M, Saeki K, Kimura T, et al. (2000) Tea catechins and related polyphenols as anti-cancer agents. Biofactors 13:81–85PubMed
20.
go back to reference Kaehler J, Sill B, Koester R, et al. (2002) Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clin Sci 103 Suppl 48:176S–178SPubMed Kaehler J, Sill B, Koester R, et al. (2002) Endothelin-1 mRNA and protein in vascular wall cells is increased by reactive oxygen species. Clin Sci 103 Suppl 48:176S–178SPubMed
21.
go back to reference Kahaleh MB (1991) Endothelin, an endothelial-dependent vasoconstrictor in scleroderma: enhanced production and profibrotic action. Arthritis Rheum 34:978–983PubMed Kahaleh MB (1991) Endothelin, an endothelial-dependent vasoconstrictor in scleroderma: enhanced production and profibrotic action. Arthritis Rheum 34:978–983PubMed
22.
go back to reference Kahler J, Mendel S, Weckmuller J, et al. (2000) Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J Mol Cell Cardiol 32:1429–1437PubMedCrossRef Kahler J, Mendel S, Weckmuller J, et al. (2000) Oxidative stress increases synthesis of big endothelin-1 by activation of the endothelin-1 promoter. J Mol Cell Cardiol 32:1429–1437PubMedCrossRef
23.
go back to reference Lee JH, Chun YG, Lee IC, et al. (2001) Pathogenic role of endothelin-1 in hemodynamic dysfunction in experimental acute pulmonary thromboembolism. Am J Respir Crit Care Med 164:1282–1287PubMed Lee JH, Chun YG, Lee IC, et al. (2001) Pathogenic role of endothelin-1 in hemodynamic dysfunction in experimental acute pulmonary thromboembolism. Am J Respir Crit Care Med 164:1282–1287PubMed
24.
go back to reference Mallat A, Fouassier L, Preaux AM, et al. (1995) Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells: an endothelin B receptor-mediated pathway. J Clin Invest 96:42–49PubMedCrossRef Mallat A, Fouassier L, Preaux AM, et al. (1995) Growth inhibitory properties of endothelin-1 in human hepatic myofibroblastic Ito cells: an endothelin B receptor-mediated pathway. J Clin Invest 96:42–49PubMedCrossRef
25.
go back to reference Minkes RK, Bellan JA, Saroyan RM, et al. (1990) Analysis of cardiovascular and pulmonary responses to endothelin-1 and endothelin-3 in the anesthetized cat. J Pharmacol Exp Ther 253:1118–1125PubMed Minkes RK, Bellan JA, Saroyan RM, et al. (1990) Analysis of cardiovascular and pulmonary responses to endothelin-1 and endothelin-3 in the anesthetized cat. J Pharmacol Exp Ther 253:1118–1125PubMed
26.
go back to reference Nakano J, Takizawa H, Ohtoshi T, et al. (1994) Endotoxin and proinflammatory cytokines stimulate endothelin-1 expression and release by airway epithelial cells. Clin Exp Allergy 24:330–336PubMedCrossRef Nakano J, Takizawa H, Ohtoshi T, et al. (1994) Endotoxin and proinflammatory cytokines stimulate endothelin-1 expression and release by airway epithelial cells. Clin Exp Allergy 24:330–336PubMedCrossRef
27.
go back to reference Okabe S, Ochiai Y, Aida M, et al. (1999) Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn J Cancer Res 90:733–739PubMed Okabe S, Ochiai Y, Aida M, et al. (1999) Mechanistic aspects of green tea as a cancer preventive: effect of components on human stomach cancer cell lines. Jpn J Cancer Res 90:733–739PubMed
28.
go back to reference Park SH, Saleh D, Giaid A, Michel RP (1997) Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist. Am J Respir Crit Care Med 156:600–608PubMed Park SH, Saleh D, Giaid A, Michel RP (1997) Increased endothelin-1 in bleomycin-induced pulmonary fibrosis and the effect of an endothelin receptor antagonist. Am J Respir Crit Care Med 156:600–608PubMed
29.
go back to reference Peacock AJ, Dawes KE, Shock A, et al. (1992) Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 7:492–429PubMed Peacock AJ, Dawes KE, Shock A, et al. (1992) Endothelin-1 and endothelin-3 induce chemotaxis and replication of pulmonary artery fibroblasts. Am J Respir Cell Mol Biol 7:492–429PubMed
30.
go back to reference Sachinidis A, Seul C, Seewald S, et al. (2000) Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. FEBS Lett 471:51–55PubMedCrossRef Sachinidis A, Seul C, Seewald S, et al. (2000) Green tea compounds inhibit tyrosine phosphorylation of PDGF beta-receptor and transformation of A172 human glioblastoma. FEBS Lett 471:51–55PubMedCrossRef
31.
go back to reference Schoenberger CI, Rennard SI, Bitterman PB, et al. (1984) Paraquat-induced pulmonary fibrosis. Role of the alveolitis in modulating the development of fibrosis. Am Rev Respir Dis 129:168–173PubMed Schoenberger CI, Rennard SI, Bitterman PB, et al. (1984) Paraquat-induced pulmonary fibrosis. Role of the alveolitis in modulating the development of fibrosis. Am Rev Respir Dis 129:168–173PubMed
32.
go back to reference Skillrud DM, Martin WJ 2nd (1984) Paraquat-induced injury of type II alveolar cells. An in vitro model of oxidant injury. Am Rev Respir Dis 129:995–999PubMed Skillrud DM, Martin WJ 2nd (1984) Paraquat-induced injury of type II alveolar cells. An in vitro model of oxidant injury. Am Rev Respir Dis 129:995–999PubMed
33.
go back to reference Smith LL (1987) Mechanism of paraquat toxicity in lung and its relevance to treatment. Hum Toxicol 6:31–36PubMedCrossRef Smith LL (1987) Mechanism of paraquat toxicity in lung and its relevance to treatment. Hum Toxicol 6:31–36PubMedCrossRef
34.
go back to reference Smith P, Heath D, Kay JM (1974) The pathogenesis and structure of paraquat-induced pulmonary fibrosis in rats. J Pathol 114:57–67PubMedCrossRef Smith P, Heath D, Kay JM (1974) The pathogenesis and structure of paraquat-induced pulmonary fibrosis in rats. J Pathol 114:57–67PubMedCrossRef
35.
go back to reference Sueoka N, Suganuma M, Sueoka E, et al. (2001) A new function of green tea: prevention of lifestyle-related disease. Ann N Y Acad Sci 928:274–280PubMedCrossRef Sueoka N, Suganuma M, Sueoka E, et al. (2001) A new function of green tea: prevention of lifestyle-related disease. Ann N Y Acad Sci 928:274–280PubMedCrossRef
36.
go back to reference Williams SN, Shih H, Guenette DK, et al. (2000) Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression. Chem Biol Interact 128:211–229PubMedCrossRef Williams SN, Shih H, Guenette DK, et al. (2000) Comparative studies on the effects of green tea extracts and individual tea catechins on human CYP1A gene expression. Chem Biol Interact 128:211–229PubMedCrossRef
37.
go back to reference Xu FP, Chen MS, Wang YZ, et al. (2004) Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 110:1269–1275PubMedCrossRef Xu FP, Chen MS, Wang YZ, et al. (2004) Leptin induces hypertrophy via endothelin-1-reactive oxygen species pathway in cultured neonatal rat cardiomyocytes. Circulation 110:1269–1275PubMedCrossRef
38.
go back to reference Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ (1989) Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 14:175–785PubMed Zhao BL, Li XJ, He RG, Cheng SJ, Xin WJ (1989) Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys 14:175–785PubMed
Metadata
Title
Green Tea Extract Inhibits Paraquat-Induced Pulmonary Fibrosis by Suppression of Oxidative Stress and Endothelin-l Expression
Authors
Hak-Ryul Kim
Byung-Kyu Park
Yeon-Mok Oh
Yun-Song Lee
Dong-Soon Lee
Hyun-Kuk Kim
Joo-Young Kim
Tae-Sun Shim
Sang-Do Lee
Publication date
01-10-2006
Publisher
Springer-Verlag
Published in
Lung / Issue 5/2006
Print ISSN: 0341-2040
Electronic ISSN: 1432-1750
DOI
https://doi.org/10.1007/s00408-005-2592-x

Other articles of this Issue 5/2006

Lung 5/2006 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.